Drugs / Dukoral
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Dukoral | — | 2004-04-28 | europa.eu ↗ |
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00820144 | Apr 2006 | infectious disease | Centre Hospitalier Universitaire de Nice | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00751933 | Oct 2008 → Oct 2009 | ulcerative colitis | Haukeland University Hospital | Terminated | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT06104345 | Oct 2023 → Jun 2024 | cholera, typhoid fever | Helsinki University Central Hospital | Completed | No outcome recorded |
| Phase 4 | NCT01109914 | Apr 2010 → Mar 2015 | — | Leiden University Medical Center | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00464867 | Jan 2006 | cholera | International Centre for Diarrhoeal Disease Research, Bangladesh | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07270796 Comparator | Jan → Jul 2027 expected | vaccinia | International Vaccine Institute | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dukoral | “The oral cholera vaccine Dukoral will be administered to all study participants in two doses,two weeks between doses.” NCT00464867 ↗5“Oral cholera vaccine (Dukoral®) on Days 0 and 7.” NCT06104345 ↗ |
| Modality | Vaccine | “The oral cholera vaccine Dukoral” NCT00464867 ↗ |
| Route | Oral | “The oral cholera vaccine Dukoral will be administered” NCT00464867 ↗ |